publication venue for
- Amyloid and tau-PET in early-onset AD: Baseline data from the Longitudinal Early-onset Alzheimer's Disease Study (LEADS). 2023
- Baseline neuropsychiatric symptoms and psychotropic medication use midway through data collection of the Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) cohort. 2023
- Cerebrospinal fluid biomarkers in the Longitudinal Early-onset Alzheimer's Disease Study. 2023
- Effects of the active amyloid beta immunotherapy CAD106 on PET measurements of amyloid plaque deposition in cognitively unimpaired APOE ε4 homozygotes. 2023
- Influence of amyloid and diagnostic syndrome on non-traditional memory scores in early-onset Alzheimer's disease. 2023
- Learning slopes in early-onset Alzheimer's disease. 2023
- Pathogenic variants in the Longitudinal Early-onset Alzheimer's Disease Study cohort. 2023
- Profiling baseline performance on the Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) cohort near the midpoint of data collection. 2023
- Sex and APOE ε4 carrier effects on atrophy, amyloid PET, and tau PET burden in early-onset Alzheimer's disease. 2023
- The Sporadic Early-onset Alzheimer's Disease Signature Of Atrophy: Preliminary Findings From The Longitudinal Early-onset Alzheimer's Disease Study (LEADS) Cohort. 2023
- White matter hyperintensities are higher among early-onset Alzheimer's disease participants than their cognitively normal and early-onset nonAD peers: Longitudinal Early-onset Alzheimer's Disease Study (LEADS). 2023
- Poster: Mild cognitive impairment and rheumatoid arthritis 2020
- Poster: Variation in retinal microvascular parameters is associated with mild cognitive impairment and Alzheimer’s disease: Epidemiology / Innovative methods in epidemiology (i.e., assessment methods, design, recruitment strategies, statistical methods, etc.) 2020
- Poster: P3-328: Does Insulin Resistance Influence White Matter Lesions In Non-diabetic Ad Subjects? 2019